These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 17153280)

  • 1. Restoring normal sinus rhythm in atrial fibrillation : evidence from pharmacologic therapy and catheter ablation trials.
    Zimetbaum P
    Curr Cardiol Rep; 2006 Sep; 8(5):377-86. PubMed ID: 17153280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rate versus rhythm control in patients with atrial fibrillation: what the trials really say.
    Crijns HJ
    Drugs; 2005; 65(12):1651-67. PubMed ID: 16060699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness and safety of transcatheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy.
    Gaita F; Di Donna P; Olivotto I; Scaglione M; Ferrero I; Montefusco A; Caponi D; Conte MR; Nistri S; Cecchi F
    Am J Cardiol; 2007 Jun; 99(11):1575-81. PubMed ID: 17531584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rhythm control for management of patients with atrial fibrillation: balancing the use of antiarrhythmic drugs and catheter ablation.
    Viles-Gonzalez JF; Fuster V; Halperin J; Calkins H; Reddy VY
    Clin Cardiol; 2011 Jan; 34(1):23-9. PubMed ID: 21259274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Catheter Ablation versus Antiarrhythmic Drug Therapy for Atrial Fibrillation (CABANA) Trial: Study Rationale and Design.
    Packer DL; Mark DB; Robb RA; Monahan KH; Bahnson TD; Moretz K; Poole JE; Mascette A; Rosenberg Y; Jeffries N; Al-Khalidi HR; Lee KL;
    Am Heart J; 2018 May; 199():192-199. PubMed ID: 29754661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of the real world effectiveness of catheter ablation and drug therapy in atrial fibrillation patients in a Chinese setting.
    Du X; Guo L; He X; Jia Y; Wu J; Long D; Yu R; Sang C; Liu X; Yin H; Xuan J; Dong J; Ma C
    BMC Cardiovasc Disord; 2017 Jul; 17(1):204. PubMed ID: 28750608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials.
    Naccarelli GV; Wolbrette DL; Khan M; Bhatta L; Hynes J; Samii S; Luck J
    Am J Cardiol; 2003 Mar; 91(6A):15D-26D. PubMed ID: 12670638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rhythm versus rate control after ablation and pacing for paroxysmal atrial fibrillation: clinical implications of the PAF 2 trial.
    Brignole M
    Card Electrophysiol Rev; 2003 Jun; 7(2):127-9. PubMed ID: 14618035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized Study of Persistent Atrial Fibrillation Ablation: Ablate in Sinus Rhythm Versus Ablate Complex-Fractionated Atrial Electrograms in Atrial Fibrillation.
    Bassiouny M; Saliba W; Hussein A; Rickard J; Diab M; Aman W; Dresing T; Callahan T; Bhargava M; Martin DO; Shao M; Baranowski B; Tarakji K; Tchou PJ; Hakim A; Kanj M; Lindsay B; Wazni O
    Circ Arrhythm Electrophysiol; 2016 Feb; 9(2):e003596. PubMed ID: 26857909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risks and benefits of rate control versus maintenance of sinus rhythm.
    Saxonhouse SJ; Curtis AB
    Am J Cardiol; 2003 Mar; 91(6A):27D-32D. PubMed ID: 12670639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sinus rhythm restoration and treatment success: insight from recent clinical trials.
    Saliba W; Wazni OM
    Clin Cardiol; 2011 Jan; 34(1):12-22. PubMed ID: 21259273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hybrid treatment of atrial fibrillation.
    Kumar P; Kiser AC; Gehi AK
    Prog Cardiovasc Dis; 2015; 58(2):213-20. PubMed ID: 26272471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hybrid therapy of atrial fibrillation: algorithms and outcome.
    Saksena S; Madan N
    J Interv Card Electrophysiol; 2003 Oct; 9(2):235-47. PubMed ID: 14574037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacologic and Nonpharmacologic Management of Atrial Fibrillation.
    Dahya V; Taigen TL
    Med Clin North Am; 2019 Sep; 103(5):835-846. PubMed ID: 31378329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minimally Invasive Stand-Alone Cox Maze Procedure for Persistent and Long-Standing Persistent Atrial Fibrillation: Perioperative Safety and 5-Year Outcomes.
    Ad N; Holmes SD; Friehling T
    Circ Arrhythm Electrophysiol; 2017 Nov; 10(11):. PubMed ID: 29138143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atrial fibrillation: cure or treat?
    Forleo GB; Tondo C
    Ther Adv Cardiovasc Dis; 2009 Jun; 3(3):187-96. PubMed ID: 19443515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Epidemiology and therapy of atrial fibrillation].
    Capucci A; Aschieri D; Villani GQ
    Ann Ital Med Int; 1996 Oct; 11 Suppl 2():5S-10S. PubMed ID: 9004821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In the wake of the AFFIRM trial: what we still don't know about the management of atrial fibrillation and where we need to go.
    Wyse DG
    Card Electrophysiol Rev; 2003 Jun; 7(2):130-5. PubMed ID: 14618036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rate versus rhythm control for atrial fibrillation.
    Halsey C; Chugh A
    Cardiol Clin; 2014 Nov; 32(4):521-31. PubMed ID: 25443234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rate control versus rhythm control in atrial fibrillation: lessons learned from clinical trials of atrial fibrillation.
    Waldo AL
    Prog Cardiovasc Dis; 2015; 58(2):168-76. PubMed ID: 26260611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.